Catalent Inc. in the News
J&J COVID-19 vaccine manufacturing halted at US plant that had contamination issue
Production of Johnson & Johnson’s (JNJ.N) COVID-19 vaccine at a U.S. manufacturing plant was halted by the U.S. Food and Drug Administration while the agency investigates an error that led to millions of doses being ruined last month.